Concentration-controlled everolimus versus MMF in De Novo heart transplant patients:: Incidence of CMV infection at 12 months post-transplant in a randomized trial

被引：1
|
作者：
Dengler, T. [1 ]
Vigano, M. [2 ]
Magelli, C. [3 ]
Guillemain, R. [4 ]
Varnous, S. [5 ]
Gerosa, G. [6 ]
Poncelet, A. [7 ]
Vanhaecke, J. [8 ]
Li, Y. [9 ]
Gezahegen, Y. [9 ]
机构：
[1] Heidelberg Univ, Heidelberg, Germany
[2] Univ Pavia, IRCCS, Policlin S Matteo, I-27100 Pavia, Italy
[3] Az Osp Bologna, Policlin S Orsola Malpighi, Bologna, Italy
[4] Europeen Georges Pompidou, Paris, France
[5] Hop La Pitie Salpetriere, Paris, France
[6] Univ Padua, Azienda Osped Padova, Padua, Italy
[7] Clin Univ St Luc, Brussels, Belgium
[8] Univ Hosp Gasthuisberg, Louvain, Belgium
[9] Novartis Pharma AG, Basel, Switzerland
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2008年 / 27卷 / 02期
关键词：
D O I：
10.1016/j.healun.2007.11.020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：S65 / S66
页数：2
相关论文
共 50 条
  • [1] Incidence of CMV infection with concentration-controlled everolimus or MMF:: 12-month results from a randomized trial in de novo heart transplant patients
    Pellegrini, Carlo
    Dengler, Thomas
    Branzi, Angelo
    Guillemain, Romain
    Varnous, Shaida
    Gerosa, Gino
    Poncelet, Alain
    Vanhaecke, Johan
    Li, Yulan
    Gezahegen, Yonas
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 : 571 - 571
  • [2] De Novo concentration-controlled everolimus is associated with a decreased incidence of CMV infection in cardiac transplant recipients
    Bara, C.
    Wang, S. -S.
    Zuckermann, A.
    Ross, H.
    Frigerio, M.
    Eisen, H. J.
    Laufer, G.
    Cotrufo, M.
    Keogh, A. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2008, 27 (02): : S66 - S66
  • [3] EVEROLIMUS ENABLES TACROLIMUS AND STEROID MINIMIZATION WITH REDUCED INCIDENCE OF CMV INFECTION AND PRESERVED GRAFT FUNCTION IN DE NOVO RENAL TRANSPLANT RECIPIENTS AT 12 AND 24 MONTHS POST-TRANSPLANT
    Esmeraldo, Ronaldo M.
    Sandes-Freitas, Taina M.
    Girao, Celi M.
    Oliveira-Sales, Maria Lmb
    Pinheiro, Petrucia Ma
    TRANSPLANT INTERNATIONAL, 2017, 30 : 64 - 64
  • [4] Lower Incidence of Viral Infections with Everolimus Versus MMF in De Novo Heart Transplant Recipients: 12 Month Analysis of a Randomized Multicenter Study
    Ross, H.
    Kfoury, A. G.
    Van Bakel, A.
    Ewald, G.
    Burton, J.
    Andreassen, A.
    Segovia, J.
    Lopez, P.
    Cines, M.
    Dong, G.
    Potena, L.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04): : S63 - S64
  • [5] A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus
    Hill, James A.
    Hummel, Manfred
    Starling, Randall C.
    Kobashigawa, Jon A.
    Perrone, Sergio V.
    Arizon, Jose M.
    Simonsen, Svein
    Abeywickrama, Kamal H.
    Bara, Christoph
    TRANSPLANTATION, 2007, 84 (11) : 1436 - 1442
  • [6] Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in De Novo Renal Transplant Recipients: Efficacy Results at 24 Months.
    Tedesco-Silva, H.
    Kim, Y. S.
    Johnston, T.
    Walker, R.
    Zibari, G. B.
    Cornu-Artis, C.
    Wang, Z.
    Cibrik, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 46 - 46
  • [7] EFFICACY AND SAFETY OF 24 MONTHS IMMUNOSUPPRESSION WITH CONCENTRATION-CONTROLLED EVEROLIMUS AND REDUCED CYCLOSPORINE IN DE NOVO RENAL TRANSPLANT RECIPIENTS
    Yaqoob, M.
    Riad, H.
    Pattison, J.
    Cornu-Artis, C.
    Wang, Z.
    Tedesco Silva, H.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 39 - 39
  • [8] Incidence of CMV infections within the first 6 months after cardiac transplantation:: concentration-controlled everolimus vs MMF
    Vigano, Mario
    Magelli, Carlo
    Boissonnat, Pascale
    Gandjbakhch, Iradj
    Gerosa, Gino
    Poncelet, Alain
    Dengler, Thomas
    Vanhaecke, Johan
    Abeywickrama, Kamal
    Gezahegen, Y. Amanuel
    TRANSPLANT INTERNATIONAL, 2007, 20 : 95 - 96
  • [9] Concentration-Controlled Everolimus with Reduced Cyclosporine Concentration in Japanese De Novo Renal Transplant Recipients: Efficacy and Safety Results at 12 Months: Japanese Multicenter Study
    Yoshimura, N.
    Uchida, K.
    Takahara, S.
    Teraoka, S.
    Kobayashi, E.
    Teshima, R.
    Cornu-Artis, C.
    Takahashi, K.
    TRANSPLANTATION, 2012, 94 (10) : 990 - 990
  • [10] Everolimus With Reduced Cyclosporine Versus MMF With Standard Cyclosporine in De Novo Heart Transplant Recipients
    Lehmkuhl, Hans B.
    Arizon, Jose
    Vigano, Mario
    Almenar, Luis
    Gerosa, Gino
    Maccherini, Massimo
    Varnous, Shaida
    Musumeci, Francesco
    Hexham, J. Mark
    Mange, Kevin C.
    Livi, Ugolino
    TRANSPLANTATION, 2009, 88 (01) : 115 - 122
12345